{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:39:30Z","timestamp":1773272370275,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T00:00:00Z","timestamp":1542758400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2018R1A2B6006223"],"award-info":[{"award-number":["NRF-2018R1A2B6006223"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12859-018-2490-x","type":"journal-article","created":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T08:47:49Z","timestamp":1542790069000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Drug repositioning using drug-disease vectors based on an integrated network"],"prefix":"10.1186","volume":"19","author":[{"given":"Taekeon","family":"Lee","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7420-4968","authenticated-orcid":false,"given":"Youngmi","family":"Yoon","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2018,11,21]]},"reference":[{"issue":"1","key":"2490_CR1","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/nbt.2786","volume":"32","author":"M HAY","year":"2014","unstructured":"HAY M, Thomas DW, Craighead JL, Economides C, Rosenthal J. Clinical development success rates for investigational drugs. Nat Biotechnol. 2014;32(1):40.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"2490_CR2","first-page":"2","volume":"17","author":"L Jiao","year":"2015","unstructured":"Jiao L, Zheng S, Chen B, Butte AJ, Swamidass SJ, Lu Z. A survey of current trends in computational drug repositioning. Brief Bioinform. 2015;17(1):2\u201312.","journal-title":"Brief Bioinform"},{"issue":"12","key":"2490_CR3","doi-asserted-by":"publisher","first-page":"e28025","DOI":"10.1371\/journal.pone.0028025","volume":"6","author":"L Yang","year":"2011","unstructured":"Yang L, Agarwal P. Systematic drug repositioning based on clinical side-effects. PLoS One. 2011;6(12):e28025.","journal-title":"PLoS One"},{"issue":"2","key":"2490_CR4","doi-asserted-by":"publisher","first-page":"e87864","DOI":"10.1371\/journal.pone.0087864","volume":"9","author":"H Ye","year":"2014","unstructured":"Ye H, Liu Q, Wei J. Construction of drug network based on side effects and its application for drug repositioning. PLoS One. 2014;9(2):e87864.","journal-title":"PLoS One"},{"issue":"5","key":"2490_CR5","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1186\/1752-0509-7-S5-S6","volume":"7","author":"C Wu","year":"2013","unstructured":"Wu C, Gudivada RC, Aronow BJ, Jegga AG. Computational drug repositioning through heterogeneous network clustering. BMC Syst Biol. 2013;7(5):S6.","journal-title":"BMC Syst Biol"},{"issue":"7","key":"2490_CR6","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13073-014-0052-z","volume":"6","author":"I Vogt","year":"2014","unstructured":"Vogt I, Prinz J, Campillos M. Molecularly and clinically related drugs and diseases are enriched in phenotypically similar drug-disease pairs. Genome Med. 2014;6(7):52.","journal-title":"Genome Med"},{"issue":"6","key":"2490_CR7","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1039\/c3mb25382a","volume":"9","author":"Z Wu","year":"2013","unstructured":"Wu Z, Wang Y, Chen L. Network-based drug repositioning. Mol BioSyst. 2013;9(6):1268\u201381.","journal-title":"Mol BioSyst"},{"key":"2490_CR8","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.7717\/peerj-cs.106","volume":"3","author":"JP McCusker","year":"2017","unstructured":"McCusker JP, Dumontier M, Yan R, He S, Dordick JS, McGuinness DL. Finding melanoma drugs through a probabilistic knowledge graph. PeerJ Computer Science. 2017;3:e106.","journal-title":"PeerJ Computer Science"},{"issue":"1","key":"2490_CR9","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/msb.2011.26","volume":"7","author":"A Gottlieb","year":"2011","unstructured":"Gottlieb A, Stein GY, Ruppin E, Sharan R. PREDICT: a method for inferring novel drug indications with application to personalized medicine. Mol Syst Biol. 2011;7(1):496.","journal-title":"Mol Syst Biol"},{"issue":"2","key":"2490_CR10","doi-asserted-by":"publisher","first-page":"e1002347","DOI":"10.1371\/journal.pcbi.1002347","volume":"8","author":"D Shigemizu","year":"2012","unstructured":"Shigemizu D, Hu Z, Hung J, Huang C, Wang Y, DeLisi C. Using functional signatures to identify repositioned drugs for breast, myelogenous leukemia and prostate cancer. PLoS Comput Biol. 2012;8(2):e1002347.","journal-title":"PLoS Comput Biol"},{"issue":"96","key":"2490_CR11","doi-asserted-by":"publisher","first-page":"96ra77","DOI":"10.1126\/scitranslmed.3001318","volume":"3","author":"M Sirota","year":"2011","unstructured":"Sirota M, Dudley JT, Kim J, Chiang AP, Morgan AA, Butte AJ, et al. Discovery and preclinical validation of drug indications using compendia of public gene expression data. Sci Transl Med. 2011;3(96):96ra77.","journal-title":"Sci Transl Med"},{"issue":"Suppl 1","key":"2490_CR12","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12918-015-0243-2","volume":"10","author":"H Yu","year":"2016","unstructured":"Yu H, Choo S, Park J, Jung J, Kang Y, Lee D. Prediction of drugs having opposite effects on disease genes in a directed network. BMC syst Biol. 2016;10(Suppl 1):2.","journal-title":"BMC syst Biol"},{"issue":"1","key":"2490_CR13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/nar\/27.1.29","volume":"27","author":"H Ogata","year":"1999","unstructured":"Ogata H, Goto S, Sato K, Fujibuchi W, Bono H, Kanehisa M. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 1999;27(1):29\u201334.","journal-title":"Nucleic Acids Res"},{"key":"2490_CR14","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.fob.2015.03.011","volume":"5","author":"J Li","year":"2015","unstructured":"Li J, Wang L, Guo M, Zhang R, Dai Q, Liu X, et al. Mining disease genes using integrated protein\u2013protein interaction and gene\u2013gene co-regulation information. FEBS Open Bio. 2015;5:251\u20136.","journal-title":"FEBS Open Bio"},{"issue":"suppl_1","key":"2490_CR15","first-page":"D54","volume":"33","author":"D Maglott","year":"2005","unstructured":"Maglott D, Ostell J, Pruitt KD, Tatusova T. Entrez Gene: gene-centered information at NCBI. Nucleic Acids Res. 2005;33(suppl_1):D54\u20138.","journal-title":"Nucleic Acids Res"},{"key":"2490_CR16","unstructured":"Clinical trials. \n                    https:\/\/clinicaltrials.gov\n                    \n                  \/. Accessed 14 Aug 2017."},{"issue":"3","key":"2490_CR17","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1089\/152791601750294344","volume":"2","author":"D Nishimura","year":"2001","unstructured":"Nishimura D. BioCarta. Biotech Software Internet Rep. 2001;2(3):117\u201320.","journal-title":"Biotech Software Internet Rep"},{"issue":"suppl_1","key":"2490_CR18","first-page":"D691","volume":"39","author":"D Croft","year":"2010","unstructured":"Croft D, O'Kelly G, Wu G, Haw R, Gillespie M, Stein L, et al. Reactome: a database of reactions, pathways and biological processes. Nucleic Acids Res. 2010;39(suppl_1):D691\u20137.","journal-title":"Nucleic Acids Res"},{"issue":"suppl_1","key":"2490_CR19","doi-asserted-by":"publisher","first-page":"D674","DOI":"10.1093\/nar\/gkn653","volume":"37","author":"CF Schaefer","year":"2008","unstructured":"Schaefer CF, Anthony K, Krupa S, Buchoff J, Day M, Buetow KH, et al. PID: the pathway interaction database. Nucleic Acids Res. 2008;37(suppl_1):D674\u20139.","journal-title":"Nucleic Acids Res"},{"key":"2490_CR20","unstructured":"PubMed: the bibliographic database. \n                    https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/\n                    \n                  . Accessed 16 Aug 2018."},{"issue":"1","key":"2490_CR21","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12859-017-1558-3","volume":"18","author":"M Oh","year":"2017","unstructured":"Oh M, Ahn J, Lee T, Jang G, Park C, Yoon Y. Drug voyager: a computational platform for exploring unintended drug action. BMC Bioinformatics. 2017;18(1):131.","journal-title":"BMC Bioinformatics"},{"issue":"2","key":"2490_CR22","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1089\/cmb.2011.0264","volume":"19","author":"Y Silberberg","year":"2012","unstructured":"Silberberg Y, Gottlieb A, Kupiec M, Ruppin E, Sharan R. Large-scale elucidation of drug response pathways in humans. J Comput Biol. 2012;19(2):163\u201374.","journal-title":"J Comput Biol"},{"issue":"6","key":"2490_CR23","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/clpt.2014.51","volume":"95","author":"A Gottlieb","year":"2014","unstructured":"Gottlieb A, Altman RB. Integrating systems biology sources illuminates drug action. Clin Pharmacol Ther. 2014;95(6):663.","journal-title":"Clin Pharmacol Ther"},{"issue":"11","key":"2490_CR24","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1200\/JCO.2005.03.7689","volume":"24","author":"GI Shapiro","year":"2006","unstructured":"Shapiro GI. Cyclin-dependent kinase pathways as targets for cancer treatment. J Clin Oncol. 2006;24(11):1770\u201383.","journal-title":"J Clin Oncol"},{"issue":"2","key":"2490_CR25","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/nrd4504","volume":"14","author":"U Asghar","year":"2015","unstructured":"Asghar U, Witkiewicz AK, Turner NC, Knudsen ES. The history and future of targeting cyclin-dependent kinases in cancer therapy. Nat Rev Drug Discov. 2015;14(2):130.","journal-title":"Nat Rev Drug Discov"},{"key":"2490_CR26","unstructured":"Ribeiro MT, Singh S, Guestrin C. Model-agnostic interpretability of machine learning. In: Proceedings of the ICML Workshop on Human Interpretability in Machine Learning. New York: 2016. \n                    https:\/\/arxiv.org\/abs\/1606.05386\n                    \n                  ."},{"key":"2490_CR27","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1145\/2939672.2939778","volume-title":"Proceedings of the 22nd ACM SIGKDD international conference on knowledge discovery and data mining","author":"MT Ribeiro","year":"2016","unstructured":"Ribeiro MT, Singh S, Guestrin C. Why should i trust you?: explaining the predictions of any classifier. In: Proceedings of the 22nd ACM SIGKDD international conference on knowledge discovery and data mining; 2016. p. 1135\u201344. ACM."},{"issue":"1","key":"2490_CR28","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0027-5107(01)00111-7","volume":"477","author":"Z Herceg","year":"2001","unstructured":"Herceg Z, Wang Z. Functions of poly (ADP-ribose) polymerase (PARP) in DNA repair, genomic integrity and cell death. Mutat Res. 2001;477(1):97\u2013110.","journal-title":"Mutat Res"},{"issue":"13","key":"2490_CR29","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.4161\/cc.29212","volume":"13","author":"E Kubota","year":"2014","unstructured":"Kubota E, Williamson CT, Elegbede A, Lees-Miller SP, Bebb DG, et al. Low ATM protein expression and depletion of p53 correlates with olaparib sensitivity in gastric cancer cell lines. Cell Cycle. 2014;13(13):2129\u201337.","journal-title":"Cell Cycle"},{"issue":"22","key":"2490_CR30","doi-asserted-by":"publisher","first-page":"4578","DOI":"10.1182\/blood-2010-01-265769","volume":"116","author":"W Vj","year":"2010","unstructured":"Vj W, Oldreive CE, Skowronska A, Oscier DG, Pratt G, Stankovic T, et al. The PARP inhibitor olaparib induces significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivo. Blood. 2010;116(22):4578\u201387.","journal-title":"Blood"},{"issue":"1","key":"2490_CR31","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1067\/mai.2001.115569","volume":"108","author":"DP Skoner","year":"2001","unstructured":"Skoner DP. Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. J Allergy Clin Immunol. 2001;108(1):S2\u20138.","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"2490_CR32","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1185\/030079904X3348","volume":"20","author":"G Philip","year":"2004","unstructured":"Philip G, Nayak AS, Berger WE, Leynadier F, Vrijens F, Reiss TF, et al. The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis. Curr Med Res Opin. 2004;20(10):1549\u201358.","journal-title":"Curr Med Res Opin"},{"issue":"6","key":"2490_CR33","doi-asserted-by":"publisher","first-page":"887","DOI":"10.2165\/00003495-200767060-00005","volume":"67","author":"A Nayak","year":"2007","unstructured":"Nayak A, Langdon RB. Montelukast in the treatment of allergic rhinitis. Drugs. 2007;67(6):887\u2013901.","journal-title":"Drugs"},{"issue":"8","key":"2490_CR34","doi-asserted-by":"publisher","first-page":"635","DOI":"10.7326\/0003-4819-133-8-200010170-00016","volume":"133","author":"DT Felson","year":"2000","unstructured":"Felson DT, Lawrence RC, Dieppe PA, Hirsch R, Helmick CG, Jordan JM, et al. Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med. 2000;133(8):635\u201346.","journal-title":"Ann Intern Med"},{"key":"2490_CR35","unstructured":"Sinusas K. Osteoarthritis: diagnosis and treatment. Am Fam Physician. 2012;85(1):49\u201356."},{"issue":"suppl_1","key":"2490_CR36","doi-asserted-by":"publisher","first-page":"D668","DOI":"10.1093\/nar\/gkj067","volume":"34","author":"DS Wishart","year":"2006","unstructured":"Wishart DS, Knox C, Guo AC, Shrivastava S, Hassanali M, Woolsey J, et al. DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res. 2006;34(suppl_1):D668\u201372.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2490_CR37","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12918-016-0326-8","volume":"10","author":"NB Torres","year":"2016","unstructured":"Torres NB, Altafini C. Drug combinatorics and side effect estimation on the signed human drug-target network. BMC Syst Biol. 2016;10(1):74.","journal-title":"BMC Syst Biol"},{"key":"2490_CR38","doi-asserted-by":"publisher","first-page":"bav028","DOI":"10.1093\/database\/bav028","volume":"2015","author":"J Pinero","year":"2015","unstructured":"Pinero J, Queralt-Rosinach N, Bravo A, Deu-Pons J, Bauer-Mehren AB, Furlong LI, et al. DisGeNET: a discovery platform for the dynamical exploration of human diseases and their genes. Database. 2015;2015:bav028.","journal-title":"Database"},{"issue":"D1","key":"2490_CR39","doi-asserted-by":"publisher","first-page":"D972","DOI":"10.1093\/nar\/gkw838","volume":"45","author":"AP Davis","year":"2016","unstructured":"Davis AP, Grondin CJ, Hohnson RJ, Sciaky D, King BL, Mattingly CJ, et al. The comparative toxicogenomics database: update 2017. Nucleic Acids Res. 2016;45(D1):D972\u20138.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2490_CR40","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1471-2105-13-20","volume":"13","author":"G Sales","year":"2012","unstructured":"Sales G, Calura E, Cavalieri D, Romualdi C. Graphite-a Bioconductor package to convert pathway topology to gene network. BMC Bioinformatics. 2012;13(1):20.","journal-title":"BMC Bioinformatics"},{"issue":"6","key":"2490_CR41","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1021\/ci034160g","volume":"43","author":"V Svetnik","year":"2003","unstructured":"Svetnik V, Liaw A, Tong C, Culberson JC, Sheridan RP, Feuston BP. Random forest: a classification and regression tool for compound classification and QSAR modeling. J Chem Inf Comput Sci. 2003;43(6):1947\u201358.","journal-title":"J Chem Inf Comput Sci"},{"issue":"3","key":"2490_CR42","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0304-3800(02)00257-0","volume":"160","author":"M Gevrey","year":"2003","unstructured":"Gevrey M, Dimopoulos I, Lek S. Review and comparison of methods to study the contribution of variables in artificial neural network models. Ecol Model. 2003;160(3):249\u201364.","journal-title":"Ecol Model"},{"issue":"5","key":"2490_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v028.i05","volume":"28","author":"M Kuhn","year":"2008","unstructured":"Kuhn M, Wing J, Weston S, Williams A. Caret package. J Stat Softw. 2008;28(5):1\u201326.","journal-title":"J Stat Softw"},{"issue":"92","key":"2490_CR44","doi-asserted-by":"publisher","first-page":"20130950","DOI":"10.1098\/rsif.2013.0950","volume":"11","author":"G Hong","year":"2014","unstructured":"Hong G, Zhang W, Li H, Shen X, Guo Z. Separate enrichment analysis of pathways for up-and downregulated genes. J R Soc Interface. 2014;11(92):20130950.","journal-title":"J R Soc Interface"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-018-2490-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12859-018-2490-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-018-2490-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T19:07:42Z","timestamp":1574276862000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-018-2490-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,21]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2490"],"URL":"https:\/\/doi.org\/10.1186\/s12859-018-2490-x","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,21]]},"assertion":[{"value":"25 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"446"}}